BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mori S, Arima N, Ito M, Ueki Y, Abe Y, Aoyagi K, Fujiyama S. Incidence, predictive factors and severity of methotrexate-related liver injury in rheumatoid arthritis: a longitudinal cohort study. Rheumatol Adv Pract 2020;4:rkaa020. [PMID: 33134809 DOI: 10.1093/rap/rkaa020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Choi SR, Park JW, Lee EB, Park JK. Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis. Clin Rheumatol 2021. [PMID: 34115231 DOI: 10.1007/s10067-021-05811-7] [Reference Citation Analysis]
2 Ferron PJ, Gicquel T, Mégarbane B, Clément B, Fromenty B. Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury? Biochimie 2020;179:266-74. [PMID: 32891697 DOI: 10.1016/j.biochi.2020.08.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wang Y, Li Y, Liu Y, Zhang Y, Ke Z, Zhang Y, Liu Y. Patients With IBD Receiving Methotrexate Are at Higher Risk of Liver Injury Compared With Patients With Non-IBD Diseases: A Meta-Analysis and Systematic Review. Front Med (Lausanne) 2021;8:774824. [PMID: 34881269 DOI: 10.3389/fmed.2021.774824] [Reference Citation Analysis]
4 Mori S, Ogata F, Tsunoda R. Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review. Clin Rheumatol 2021;40:4457-71. [PMID: 34554329 DOI: 10.1007/s10067-021-05911-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]